Corrigendum to “The effectiveness of a program of physical activity and diet to modify cardiovascular risk factors in patients with severe mental illness after 3-month follow-up: CAPiCOR randomized clinical trial” [European Psychiatry 30 (2015) 1028–1036](S0924933815001765)(10.1016/j.eurpsy.2015.09.006);The effectiveness of a program of physical activity and diet to modify cardiovascular risk factors in patients with severe mental illness after 3-month follow-up: CAPiCOR randomized clinical trial

European Psychiatry

Volumn 30, Issue 8, 2015, Pages 1028-1036

  Masa Font, R ^a   Fernandez San Martin M I ^b   Martin Lopez L M ^c   Alba Munoz A M ^d   Oller Canet, S ^e   Martin Royo J ^f   San Emeterio Echevarria L ^g   Olona Tabuena N ^h   Ibarra Jato, M ^g   Barroso Garcia A ⁱ   Gonzalez Tejon S ^j   Tajada Vitales, C ^k   Diaz Mujica B ^l   Vinas Cabrera L ^m   Sanchis Catalan R ^l   Salvador Barbarroja, T ^g  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Unitat Docent de Medicina Preventiva   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d PARC SANITARI SANT JOAN DE DÉU   (Spain)

^e Centre de Salut Mental Marti Julia   (Spain)

^f CUAP Casernes (ICS)   (Spain)

^g Institut Catalá de Salut   (Spain)

^h ASSIR de Barcelona   (Spain)

ⁱ EAP Sant Martí de Provençals   (Spain)

^j EAP Raval Sud   (Spain)

^k EAP Doctor Vilaseca (Can Mariner)   (Spain)

^l Centre Salut Mental Sant Martí Sud INAD   (Spain)

^m EAP Poblenou   (Spain)

more..

Author keywords

Bipolar disorder; Cardiovascular risk factors; Diet; Physical activity; Quality of life; Schizophrenia

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL; NEUROLEPTIC AGENT;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BIPOLAR DISORDER; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIETARY INTAKE; EMOTIONALITY; FEMALE; FOLLOW UP; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MENTAL HEALTH; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIET THERAPY; KINESIOTHERAPY; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PSYCHOTIC DISORDERS; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIET THERAPY; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PSYCHOTIC DISORDERS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84955442449     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2016.10.004     Document Type: Erratum

References (39)

1. Abbott M, Arthur A, Walker L, Doody G. The challenge of recruiting people with schizophrenia to a health promotion trial. Br J Gen Pract 2005;55(517):634-6.
2. Aguilar E, Coronas R, Caixàs A. Síndrome metabólico en pacientes esquizofrénicos con tratamiento antipsicótico. Med Clin (Barc) 2012;139(12):542-6.
3. Bellivier F. Schizophrenia, antipsychotics and diabetes: genetic aspects. Eur Psychiatry 2005;20(Suppl. 4):S335-9.
4. Bernardo M, Grazia M. Esquizofrenia y Medicina de Familia. Implicaciones en Atención Primaria. Jano 2008;1714:37-44.
5. Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M, Rejas J, et al. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study. Eur Psychiatry 2012;27(4):267-74.
6. Bou Khalil R. Metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake. Presse Med 2012;41(5):e238-43.
7. Casañas R, Catalán R, del Val JL, Real J, Valero S, Casas M. Effectiveness of a psycho-educational group program for major depression in primary care: a randomized controlled trial. BMC Psychiatry 2012;12:230. http://dx.doi.org/10.1186/1471-244X-12-230.
8. Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv Rev Psychiatry 2006;14(4):212-22.
9. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-95.
10. Daumit G, Dickerson F, Wang N, Dalcin A, Jerome G, Anderson C, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med 2013;368(17):1594-602. http://dx.doi.org/10.1056/NEJMoa1214530.
11. Estruch R, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368(14):1279-90.
12. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007;1:CD005148.
13. Faulkner G1, Cohn T, Remington G. Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr Res 2006;82(2-3):225-31 [Epub 2005 Dec 19].
14. Fernández-San-Martín MI, Martín-López LM, Masa-Font R, Olona-Tabueña N, Roman Y, Martin-Royo J, et al. The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: metaanalysis of intervention studies. Community Ment Health J 2014;50(1):81-95. http://dx.doi.org/10.1007/s10597-013-9614-6.
15. Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and metaanalysis of exercise interventions in schizophrenia patients. Psychol Med 2015;45(7):1343-61.
16. Fuller NR, Williams K, Shrestha R, Ahern AL, Holzapfel C, Hauner H, et al. Changes in physical activity during a weight loss intervention and follow-up: a randomized controlled trial. Clin Obes 2014;4(3):127-35. http://dx.doi.org/10.1111/cob.12057 [Epub 2014 Apr 23].
17. Guy W. Clinical global impression (CGI). In: Guy W, editor. ECDEU assessment manual for psychopharmacology. Rockville: US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH. Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976. p. 218-22.
18. Heggelund J, Morken G, Helgerud J, Nilsberg GE, Hoff J. Therapeutic effects of maximal strength training on walking efficiency in patients with schizophrenia -a pilot study. BMC Res Notes 2012;5:344. http://dx.doi.org/10.1186/1756-0500-5-344.
19. Holley J, Crone D, Tyson P, Lovell G. The effects of physical activity on psychological well-being for those with schizophrenia: a systematic review. Br J Clin Psychol 2011;50(1):84-105.
20. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27(3 Suppl.):S178-89.
21. Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 2012;25(2): 83-8.
22. Leese M, Schene A, Koeter M, Meijer K, Bindman J, Mazzi M, et al. SF-36 scales, and simple sums of scales, were reliable quality-of-life summaries for patients with schizophrenia. J Clin Epidemiol 2008;61(6):588-96. http://dx.doi.org/10.1016/j.jclinepi.2007.08.004 [Epub 2008 Feb 14].
23. Llibre blanc. Consens sobre les activitats preventives a l'edat adulta dins l'atencióprimària. Barcelona (España): Direcció General de Salut Pública, Departament de Salud, Generalitat de Cataluña; 2005.
24. Lovell K, Wearden A, Bradshaw T, Tomenson B, Pedley R, Davies LM, et al. An exploratory randomized controlled study of a healthy living intervention in early intervention services for psychosis: the INTERvention to encourage ACTivity, improve diet, and reduce weight gain (INTERACT) study. J Clin Psychiatry 2014;75(5):498-505. http://dx.doi.org/10.4088/JCP.13m08503.
25. Marshall M, Barrowclough C, Drake R, Husain N, Lobban F, Lovell K, et al. The HELPER programme: HEalthy Living and Prevention of Early Relapse -three exploratory randomised controlled trials of phase-specific interventions in first-episode psychosis. Southampton (UK): NIHR Journals Library; 2015.
26. Martinez-Gonzalez MA, Fernandez-Jarne E, Serrano-Martinez M, Wright M, Gomez-Gracia E. Development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet. Eur J Clin Nutr 2004;58:1550-2.
27. Masa-Font R, Fernández-San-Martín MI, Martín-López LM, Olona-Tabueña N, Oller-Canet S, San-Emeterio-Echevarría L, et al. Effectiveness of a program of physical activity and diet to modify cardiovascular risk factors in patients with severe mental illness (CAPiCOR Study): study protocol. Int Arch Med 2015;8(97):1-12. http://dx.doi.org/10.3823/1696.
28. Medeiros L, Obiols J, Navarro JB, Zúñiga A. Metabolic syndrome and health related quality of life in patients with schizophrenia. Actas Esp Psiquiatr 2013;41(1):17-26.
29. O'Donell CJ, Elosua R. Cardiovascular risk factors. Insights from Framingham Heart Study. Rev Esp Cardiol 2006;61(3):299-310.
30. Oud M, Meyboom-de Jong B. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract 2009;10:32.
31. Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, et al. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry 2007;41:980-9.
32. Sáiz J, Bobes J, Vallejo J, Giner J, García-Portilla MP, Grupo de Trabajo sobre la Salud Física del Paciente con Esquizofrenia. Consensus on physical health of patients with schizophrenia from the Spanish societies of Psychiatry. Actas Esp Psiquiatr 2008;36:251-64.
33. Salas-Salvadó J, Rubio MA, Barbany M, Moreno B, Grupo Colaborativo de la SEEDO. Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc) 2007;128(5):184-96.
34. Scheewe TW, Backx FJG, Takken T, Jorg F, Van Strater ACP, Kroes AG, et al. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand 2013;127:464-73.
35. Ter Meulen WG, de Haan L. Exercise-promoting interventions for encouraging people with schizophrenia to take physical exercise. Tijdschr Psychiatr 2012;54(8):741-6.
36. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2010;6:CD007253.
37. Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, et al. El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit 2005;19(2):135-50.
38. Viñas L, Fernández M, San Emeterio L, Martín-López LM, Grup Psicosi Litoral. Detección de factores de riesgo cardiovascular en pacientes con psicosis. Aten Primaria 2011;43(7):386-7. http://dx.doi.org/10.1016/j.aprim.2010.04.021.
39. Viron M, Baggett T, Hill M, Freudenreich O. Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population. Am J Med 2012;125(3):223-30.